NEWRON PHARMACEUTICALS S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.28 CHF | +8.82% |
|
+4.75% | +47.07% |
| Apr. 17 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
| Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Newron Pharmaceuticals S.p.A.
Price target over the last 5 years
History of analyst recommendation changes
3772c9d9d6022ef3be57de6ed7.uZw_jHkuAgyiDDDDO5E9tMQVctI_4J6Kaasrs_K_4rc.0O901RUYdjTuYECsS8cMzP1xBrVLsfPtEYZc3p_4ieXIzUrIL2I3dvM5CA~37a71122442a051ab0d1114b1ffa7a5f
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.455
EUR
Average target price
13.28
EUR
Spread / Average Target
+78.16%
High Price Target
14.11
EUR
Spread / Highest target
+89.23%
Low Price Target
12.75
EUR
Spread / Lowest Target
+71.05%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- NWRN Stock
- Consensus Newron Pharmaceuticals S.p.A.
